Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature
Hemodialysis International · 2024
DOI: 10.1111/hdi.13181 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hemodialysis International, 2024. Verfasst von Tanguy Viaene und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Hirudins, Recombinant Proteins, Renal Dialysis, Peptide Fragments. Die Arbeit nennt 33 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Unfractionated heparin is the most used anticoagulative agent for extracorporeal settings in children, including acute hemodialysis modalities. In certain situations, such as heparin‐induced thrombocytopenia, alternatives must be applied. The direct thrombin inhibitor bivalirudin has come forth as an attractive substitute. Bivalirudin is currently only approved for adult use in specific percutaneous coronary intervention settings. However, it has a growing off‐label popularity in different contexts for both adult and pediatric patients. Experience with bivalirudin in children is mainly limited to extracorporeal membrane oxygenation, ventricular assist devices and during cardiopulmonary bypass surgery. Literature about its use as anticoagulation strategy for pediatric hemodialysis is very scarce. Here, we present two pediatric cases where bivalirudin was used during acute hemodialysis, followed by a short summary of recent literature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Ghent University Hospital, Ghent, Belgium.
- Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium.
- Department of Nephrology, Member of the European Reference Network for Rare Kidney Diseases (ERKNet), Ghent University Hospital, Ghent, Belgium.
- Department of Human Structure and Repair, Ghent University Hospital, Ghent, Belgium.
- Department of Pediatric Hematology & Oncology, Ghent University Hospital, Ghent, Belgium.
- Department of Pediatric Nephrology, Member of the European Reference Network for Rare Kidney Diseases (ERKNet), Ghent University Hospital, Ghent, Belgium.
ORCID-Profile: Tanguy Viaene, Evelyn Dhont, Sunny Eloot, Filip De Somer, Veerle Mondelaers, Evelien Snauwaert
Zitieren
APA
Viaene, T., Dhont, E., Vanommeslaeghe, F., Eloot, S., De Somer, F., De Rudder, J., Mondelaers, V., & Snauwaert, E. (2024). Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature. Hemodialysis International. https://doi.org/10.1111/hdi.13181
Vancouver
Viaene T, Dhont E, Vanommeslaeghe F, Eloot S, De Somer F, De Rudder J, et al. Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature. Hemodialysis International. 2024. doi:10.1111/hdi.13181
BibTeX
@article{Viaene2024,
author = {Viaene, Tanguy and Dhont, Evelyn and Vanommeslaeghe, Floris and Eloot, Sunny and De Somer, Filip and De Rudder, Jonathan and Mondelaers, Veerle and Snauwaert, Evelien},
title = {Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature},
journal = {Hemodialysis International},
year = {2024},
doi = {10.1111/hdi.13181}
}
EUVIMED